RE:RE:RE:RE:RE:Employee reviewsFGPstock ... lolll Pretty simplistic and arrogant view that even Prof. McFarland would not agree on.
A molecule alone is nothing. Go ask Prof McFarland's peers (Prof Glazier, Prof. Gasser, etc ...) that have come up with similar molecules but that never found a multidisciplinary team to make the whole thing work.
We owe it all to Sherri? Not really, but she's clearly part of a team when you considered all the additional work out of her scope needed to have her molecule retain all its efficacy. Dosimetry software was build from scratch, the decision to use of the proper light, reviewing the 1993 failure of Photofrin, etc ...
One of those don't work properly and you don't make it globally. In 1993 Photofrin had efficacy that got it FDA approval but because of another issue (impact on the bladder wall), urologists never used it.
Even Prof. McFarland acknowledges that it's a multi-disciplinary work. Dr. Rueck's innovation, all the work of Prof. Lilge, Prof. Betz, onboarding IBM and Intel, all the patents of Dr. Mandel, etc ...
Roger could have never pay attention to the request of Prof. McFarland back in 2010, persevering through all those many challenges, being involved in all the steps, convincing top minds, giving them all the lattitude to express all their talent, never cut-corners when SH posters were impatient, etc ...
Keep attributing the April 5 sudden drop to a press release missing bullet forms presentation when in fact it was simply short-sighted investors and shorts at work.